{"id":"https://openalex.org/W2136804807","doi":"https://doi.org/10.1093/eurheartj/ehu006","title":"Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation","display_name":"Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation","publication_year":2014,"publication_date":"2014-02-09","ids":{"openalex":"https://openalex.org/W2136804807","doi":"https://doi.org/10.1093/eurheartj/ehu006","mag":"2136804807","pmid":"https://pubmed.ncbi.nlm.nih.gov/24513791","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4104492"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehu006","doi":"https://doi.org/10.1093/eurheartj/ehu006","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehu006","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4104492","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084263263","display_name":"Paul Dorian","orcid":"https://orcid.org/0000-0002-8244-3520","observed_orcids":["https://orcid.org/0000-0002-8244-3520"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"P. Dorian","raw_affiliation_strings":["University of Toronto, St Michael's Hospital Toronto, Ontario, Canada dorianp@smh.ca","University of Toronto St. Michael's Hospital Toronto Ontario Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toronto, St Michael's Hospital Toronto, Ontario, Canada dorianp@smh.ca","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]},{"raw_affiliation_string":"University of Toronto St. Michael's Hospital Toronto Ontario Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042408270","display_name":"Thitima Kongnakorn","orcid":"https://orcid.org/0000-0003-3541-1478","observed_orcids":["https://orcid.org/0000-0003-3541-1478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Kongnakorn","raw_affiliation_strings":["Evidera, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Bangkok, Thailand","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110208931","display_name":"Hemant M. Phatak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20089843","display_name":"Princeton University","ror":"https://ror.org/00hx57361","country_code":"US","type":"education","lineage":["https://openalex.org/I20089843"]},{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Phatak","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I20089843","https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084783003","display_name":"Dale A. Rublee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. A. Rublee","raw_affiliation_strings":["Pfizer, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051493673","display_name":"Andreas Kuznik","orcid":"https://orcid.org/0000-0002-8634-8360","observed_orcids":["https://orcid.org/0000-0002-8634-8360"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Kuznik","raw_affiliation_strings":["Pfizer, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060092467","display_name":"Tereza Lanitis","orcid":"https://orcid.org/0000-0002-8209-8843","observed_orcids":["https://orcid.org/0000-0002-8209-8843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Lanitis","raw_affiliation_strings":["Evidera, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112142946","display_name":"Liu Lz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Z. Liu","raw_affiliation_strings":["Pfizer, New York, NY, USA Weill Medical College of Cornell University, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, New York, NY, USA Weill Medical College of Cornell University, New York, NY, USA","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108218302","display_name":"UH Iloeje","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20089843","display_name":"Princeton University","ror":"https://ror.org/00hx57361","country_code":"US","type":"education","lineage":["https://openalex.org/I20089843"]},{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U. Iloeje","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I20089843","https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080992355","display_name":"Luis G. Hernandez","orcid":"https://orcid.org/0000-0002-9532-546X","observed_orcids":["https://orcid.org/0000-0002-9532-546X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Hernandez","raw_affiliation_strings":["Evidera, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Lexington, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038405190","display_name":"Gregory Y.H. Lip","orcid":"https://orcid.org/0000-0002-7566-1626","observed_orcids":["https://orcid.org/0000-0002-7566-1626","https://orcid.org/0000-0002-2556-2945"]},"institutions":[{"id":"https://openalex.org/I2799802789","display_name":"Birmingham City Hospital","ror":"https://ror.org/02smq5q54","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799630439","https://openalex.org/I2799802789"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Y. H. Lip","raw_affiliation_strings":["University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK","institution_ids":["https://openalex.org/I2799802789","https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5084263263"],"corresponding_institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":12.0368,"has_fulltext":false,"cited_by_count":98,"citation_normalized_percentile":{"value":0.99090305,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"35","issue":"28","first_page":"1897","last_page":"1906"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":1.0},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.972000002861023},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8629999756813049},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.9089999794960022},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.8629999756813049},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7170000076293945},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9800000190734863},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.8510000109672546},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.7039999961853027},{"id":"https://openalex.org/keywords/aristotle-trial","display_name":"ARISTOTLE trial","score":0.7519999742507935},{"id":"https://openalex.org/keywords/averroes-trial","display_name":"AVERROES trial","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9414719343185425},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.910076379776001},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8482294082641602},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7078629732131958},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.659285843372345},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5834035873413086},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.515214741230011},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49495643377304077},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.43470314145088196},{"id":"https://openalex.org/C2779630707","wikidata":"https://www.wikidata.org/wiki/Q3570984","display_name":"Ximelagatran","level":5,"score":0.4295092821121216},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41214263439178467},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.39533114433288574},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32395339012145996},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.25008004903793335},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.18238356709480286},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014812","descriptor_name":"Vitamin K","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/eurheartj/ehu006","doi":"https://doi.org/10.1093/eurheartj/ehu006","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehu006","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3074503","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4104492","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4104492","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4104492","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Heart J","raw_type":"Text"},{"id":"pmid:24513791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24513791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3074503","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4104492","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W126212309","https://openalex.org/W1971505725","https://openalex.org/W1985042952","https://openalex.org/W1995044128","https://openalex.org/W1999468381","https://openalex.org/W2002003793","https://openalex.org/W2011936209","https://openalex.org/W2014757808","https://openalex.org/W2021927513","https://openalex.org/W2023143117","https://openalex.org/W2028428081","https://openalex.org/W2028933957","https://openalex.org/W2031654814","https://openalex.org/W2061923072","https://openalex.org/W2062839668","https://openalex.org/W2066157763","https://openalex.org/W2076774160","https://openalex.org/W2085270509","https://openalex.org/W2085415993","https://openalex.org/W2095783086","https://openalex.org/W2107424955","https://openalex.org/W2108745446","https://openalex.org/W2123974278","https://openalex.org/W2129613163","https://openalex.org/W2149388786","https://openalex.org/W2152495738","https://openalex.org/W2152570993","https://openalex.org/W2162508946","https://openalex.org/W2202544074","https://openalex.org/W2971005880","https://openalex.org/W3030533492","https://openalex.org/W3143265745","https://openalex.org/W4233664165","https://openalex.org/W4238251256","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2028612781","https://openalex.org/W2154960408","https://openalex.org/W2021927513","https://openalex.org/W2554164234","https://openalex.org/W7096107405","https://openalex.org/W3111638546","https://openalex.org/W2082511865","https://openalex.org/W1985042952","https://openalex.org/W2144649552","https://openalex.org/W2176270072"],"abstract_inverted_index":{"AIMS:":[0],"Warfarin,":[1],"a":[2,180,216,229],"vitamin":[3],"K":[4],"antagonist":[5],"(VKA),":[6],"has":[7,39],"been":[8],"the":[9,48,62,72,75,90,112,137,153],"standard":[10],"of":[11,65,74,93,219],"care":[12],"for":[13,25,31],"stroke":[14],"prevention":[15],"in":[16,47,100,111,152,236],"patients":[17,27,242],"with":[18,96,168,200,203,243],"atrial":[19],"fibrillation":[20],"(AF).":[21],"Aspirin":[22],"is":[23,34,228],"recommended":[24],"low-risk":[26],"and":[28,45,50,54,69,98,103,132,139,142,146,162,170,195,205,234,239],"those":[29],"unsuitable":[30,105,241],"warfarin.":[32,59],"Apixaban":[33,155],"an":[35],"oral":[36],"anticoagulant":[37],"that":[38,211],"demonstrated":[40],"better":[41],"efficacy":[42],"than":[43,58],"warfarin":[44,68,97,169,204,233],"aspirin":[46,70,99],"ARISTOTLE":[49,138],"AVERROES":[51,140],"studies,":[52],"respectively,":[53],"causes":[55],"less":[56],"bleeding":[57],"We":[60],"evaluated":[61],"potential":[63],"cost-effectiveness":[64,190],"apixaban":[66,94,201,227],"against":[67],"from":[71,136],"perspective":[73],"UK":[76],"payer":[77],"perspective.":[78],"RESULTS":[79],"AND":[80],"METHODS:":[81],"A":[82],"lifetime":[83],"Markov":[84],"model":[85,113],"was":[86,156,192],"developed":[87],"to":[88,158,176,215,232],"evaluate":[89],"pharmacoeconomic":[91],"impact":[92],"compared":[95,167,202],"VKA":[101,104,237,240],"suitable":[102,238],"patients,":[106],"respectively.":[107,207,245],"Clinical":[108],"events":[109],"considered":[110],"include":[114],"ischaemic":[115],"stroke,":[116,118],"haemorrhagic":[117],"intracranial":[119],"haemorrhage,":[120],"other":[121],"major":[122],"bleed,":[123,127],"clinically":[124],"relevant":[125],"non-major":[126],"myocardial":[128],"infarction,":[129],"cardiovascular":[130],"hospitalization":[131],"treatment":[133],"discontinuations;":[134],"data":[135],"trials":[141],"published":[143],"mortality":[144],"rates":[145,149],"event-related":[147],"utility":[148],"were":[150,174,213],"used":[151],"model.":[154],"projected":[157],"increase":[159,184],"life":[160,164],"expectancy":[161],"quality-adjusted":[163],"years":[165],"(QALYs)":[166],"aspirin.":[171],"These":[172],"gains":[173],"expected":[175],"be":[177],"achieved":[178],"at":[179],"drug":[181],"acquisition-related":[182],"cost":[183],"over":[185],"lifetime.":[186],"The":[187],"estimated":[188],"incremental":[189],"ratio":[191],"\u00a311":[193],"909":[194],"\u00a37196":[196],"per":[197],"QALY":[198],"gained":[199],"aspirin,":[206,235],"Sensitivity":[208],"analyses":[209],"indicated":[210],"results":[212],"robust":[214],"wide":[217],"range":[218],"inputs.":[220],"CONCLUSIONS:":[221],"Based":[222],"on":[223],"randomized":[224],"trial":[225],"data,":[226],"cost-effective":[230],"alternative":[231],"AF,":[244]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}